Related Experiment Video
Updated: Jan 3, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal opioid exposure: The next neonatal neuroinflammatory disease
Lauren L Jantzie1, Jessie R Maxwell2, Jessie C Newville2
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Neurology, Kennedy Krieger Institute, Baltimore, MD, United States; Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, NM, United States; Department of Neurosciences, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Insights
Prenatal methadone exposure in rats causes lasting immune system changes and brain injury, leading to cognitive deficits in adulthood. This study highlights the neurodevelopmental risks of in utero opioid exposure.
Area of Science:
- Neuroscience
- Developmental Biology
- Immunology
Background:
- Opioid use disorder in pregnancy has surged, leading to increased prenatal opioid exposure in infants.
- Long-term neurodevelopmental effects of in utero opioid exposure are not fully understood.
- A critical public health concern exists regarding the long-term outcomes for children exposed to opioids during development.
Purpose of the Study:
- To investigate the neurodevelopmental impacts of perinatal methadone exposure in a preclinical model.
- To elucidate mechanisms of neural cell injury, identify biomarkers, and guide clinical follow-up.
- To test the hypothesis that methadone exposure induces inflammation, immune dysfunction, CNS injury, and cognitive alterations.
Main Methods:
- Utilized a combination of cellular, molecular, biochemical, and imaging techniques.
- Assessed peripheral and central nervous system (CNS) inflammatory markers.
- Employed diffusion tensor imaging and touchscreen technology for cognitive assessments in adult rats.
Main Results:
- Perinatal methadone exposure increased inflammatory cytokines and primed the immune system in pups.
- Observed neuroinflammation in the brain, including altered microglia morphology and upregulated inflammatory genes.
- Detected microstructural brain injury (reduced myelin, altered neurofilaments) and cognitive impairments in learning and executive function.
Conclusions:
- Prenatal methadone exposure induces a systemic and neuroinflammatory signature.
- Findings suggest altered CNS microenvironment, developmental dysregulation, and neural injury.
- Results align with clinical observations and underscore the need for targeted therapies for affected children.
Abstract:
The rates of opioid use disorder during pregnancy have more than quadrupled in the last decade, resulting in numerous infants suffering exposure to opioids during the perinatal period, a critical period of central nervous system (CNS) development. Despite increasing use, the characterization and definition of the molecular and cellular mechanisms of the long-term neurodevelopmental impacts of opioid exposure commencing in utero remains incomplete. Thus, in consideration of the looming public health crisis stemming from the multitude of infants with prenatal opioid exposure entering school age, we undertook an investigation of the effects of perinatal methadone exposure in a novel preclinical model. Specifically, we examined the effects of opioids on the developing brain to elucidate mechanisms of putative neural cell injury, to identify diagnostic biomarkers and to guide clinical studies of outcome and follow-up. We hypothesized that methadone would induce a pronounced inflammatory profile in both dams and their pups, and be associated with immune system dysfunction, sustained CNS injury, and altered cognition and executive function into adulthood. This investigation was conducted using a combination of cellular, molecular, biochemical, and clinically translatable biomarker, imaging and cognitive assessment platforms. Data reveal that perinatal methadone exposure increases inflammatory cytokines in the neonatal peripheral circulation, and reprograms and primes the immune system through sustained peripheral immune hyperreactivity. In the brain, perinatal methadone exposure not only increases chemokines and cytokines throughout a crucial developmental period, but also alters microglia morphology consistent with activation, and upregulates TLR4 and MyD88 mRNA. This increase in neuroinflammation coincides with reduced myelin basic protein and altered neurofilament expression, as well as reduced structural coherence and significantly decreased fractional anisotropy on diffusion tensor imaging. In addition to this microstructural brain injury, adult rats exposed to methadone in the perinatal period have significant impairment in associative learning and executive control as assessed using touchscreen technology. Collectively, these data reveal a distinct systemic and neuroinflammatory signature associated with prenatal methadone exposure, suggestive of an altered CNS microenvironment, dysregulated developmental homeostasis, complex concurrent neural injury, and imaging and cognitive findings consistent with clinical literature. Further investigation is required to define appropriate therapies targeted at the neural injury and improve the long-term outcomes for this exceedingly vulnerable patient population.
